Table 1. Clinical characteristics of myeloma patients.* .
Patient Code | Diagnosis | Date of clinical sample acquisition | Treatment | Remission status (at date of sample acquisition) |
MM001 | 06/2003 | 06/2003 and 07/2008 | autologous stem cell transplant (11/2004), idiotype vaccination (06-11/2005), lenalidomide maintenance (06/2006-02/2007), lenalidomide/dexamethasone (03/2008-07/2008) | PR/SD |
MM003 | 02/2002 | 02/2002 | autologous stem cell transplant (05/2003), thalidomide maintenance, bortezomib (02-04/2005), idiotype vaccination (06-11/2005), cyclophosphamide/bortezomib/dexamethasone (02-07/2006) | active disease |
MM008 | 03/2005 | 03/2005 | autologous stem cell transplant (11/2005), allogeneic stem cell transplant (02/2006) | active disease |
MM020 | 05/2005 | 05/2005 and 09/2008 | autologous stem cell transplant (11/2005), idiotype vaccination (08/2006-09/2008) | PR |
MM021 | 09/2000 | 05/2009 | autologous stem cell transplant (11/2001 and 07/2007), lenalidomide/dexamethasone (07-12/2008), bortezomib/dexamethasone (05/2009) | PD |
MM022 | 05/2004 | 05/2009 | autologous stem cell transplant (12/2005), bortezomib/dexamethasone (12/2006-08/2007), lenalidomide/dexamethasone (01-09/2008), thalidomide/bortezomib/dexamethasone (10/2008-02/2009), allogeneic stem cell transplant (02/2009) | PD |
MM023 | 12/2008 | 03/2009 | bortezomib/dexamethasone (01-03/2009) | PR |
MM025 | 09/2005 | 08/2009 | autologous stem cell transplant (11/2005 and 01/2006), bortezomib/dexamethasone (07-08/2009) | PD |
MM026 | 08/2009 | 08/2009 | - | active disease |
MM031 | 11/2007 | 04/2010 | bortezomib/dexamethasone (12/2007-01/2008), autologous stem cell transplant (05/2008 and 08/2008), bortezomib maintenance | PD |
MM032 | 01/2011 | 01/2011 | autologous stem cell transplant (06/2011 and 09/2011) | active disease |
MM034 | 02/2011 | 02/2011 | - | active disease |
MM036 | 2007 | 02/2011 | bortezomib (01/2011) | PR |
MM048 | 03/2011 | 03/2011 | autologous stem cell transplant (09/2011) | active disease |
MM050 | 01/2003 | 04/2011 | intermittent lenalidomide (01/2003-04/2011), bortezomib/dexamethasone (04-08/2011) | PD |
*MM = multiple myeloma, PR = partial remission, SD = stable disease, PD = progressive disease.